ECONOMYEconomic Times Markets · 2 hours agoLive
Mankind Pharma Q2 profit rises 38% to Rs 716 crore
Reported by Economic Times Markets, not nibnow. We are not the publisher of this story, only the source is.
No additional analysis available for this story yet.
WHAT HAPPENED
Mankind Pharma has announced a profit increase of 37.7% to ₹716 crore during the September quarter. Revenue from operations rose to ₹4,337.9 crore compared to ₹3,697.2 crore in the same quarter last year. This growth is attributed to strong performance in both domestic and international markets. The recent acquisition of Armed Cell Therapeutics is expected to enhance R&D capabilities.
Text size
READ IN YOUR LENS
UPSCMarketsFounder